Bevacizumab With or Without Radiation Therapy in Treating Patients With Recurrent Glioblastoma
Public ClinicalTrials.gov record NCT01730950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
Study identification
- NCT ID
- NCT01730950
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Radiation Therapy Oncology Group
- Network
- Enrollment
- 182 participants
Conditions and interventions
Conditions
Interventions
- bevacizumab Biological
- radiation therapy Radiation
Biological · Radiation
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2012
- Primary completion
- Sep 2, 2018
- Completion
- Dec 21, 2022
- Last update posted
- Dec 28, 2022
2012 – 2022
United States locations
- U.S. sites
- 31
- U.S. states
- 21
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Arizona Oncology Services Foundation | Phoenix | Arizona | 85013 | — |
| Arizona Oncology-Deer Valley Center | Phoenix | Arizona | 85027 | — |
| John Muir Medical Center | Walnut Creek | California | 94598 | — |
| Yale University | New Haven | Connecticut | 06520-8032 | — |
| University of Miami Miller School of Medicine-Sylvester Cancer Center | Miami | Florida | 33136 | — |
| Queen's Medical Center | Honolulu | Hawaii | 96813 | — |
| Radiation Oncology Associates PC | Fort Wayne | Indiana | 46804 | — |
| IU Health Methodist Hospital | Indianapolis | Indiana | 46202 | — |
| Memorial Hospital of South Bend | South Bend | Indiana | 46601 | — |
| Norton Health Care Pavilion - Downtown | Louisville | Kentucky | 40202 | — |
| Maine Medical Center- Scarborough Campus | Scarborough | Maine | 04074 | — |
| Lowell General Hospital | Lowell | Massachusetts | 01854 | — |
| University of Michigan University Hospital | Ann Arbor | Michigan | 48109 | — |
| West Michigan Cancer Center | Kalamazoo | Michigan | 49007 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| Nebraska Methodist Hospital | Omaha | Nebraska | 68114 | — |
| University of Rochester | Rochester | New York | 14642 | — |
| Cone Health Cancer Center | Greensboro | North Carolina | 27403 | — |
| Summa Akron City Hospital | Akron | Ohio | 44304 | — |
| Summa Barberton Hospital | Barberton | Ohio | 44203 | — |
| Lancaster General Hospital | Lancaster | Pennsylvania | 17604 | — |
| Radiation Therapy Oncology Group | Philadelphia | Pennsylvania | 19103 | — |
| Allegheny Cancer Center at Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555-0565 | — |
| North Star Lodge Cancer Center at Yakima Valley Memorial Hospital | Yakima | Washington | 98902 | — |
| Saint Vincent Hospital | Green Bay | Wisconsin | 54301 | — |
| Saint Mary's Hospital | Green Bay | Wisconsin | 54303 | — |
| Bay Area Medical Center | Marinette | Wisconsin | 54143 | — |
| Door County Cancer Center | Sturgeon Bay | Wisconsin | 54235-1495 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01730950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2022 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01730950 live on ClinicalTrials.gov.